Managing Malignant Cerebral Infarction
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Managing patients with malignant cerebral infarction remains one of the foremost challenges in medicine. These patients are at high risk for progressive neurologic deterioration and death due to malignant cerebral edema, and they are best cared for in the intensive care unit of a comprehensive stroke center. Careful initial assessment of neurologic function and of findings on MRI, coupled with frequent reassessment of clinical and radiologic findings using CT or MRI are mandatory to promote the prompt initiation of treatments that will ensure the best outcome in these patients. Significant deterioration in either neurologic function or radiologic findings or both demand timely treatment using the best medical management, which may include osmotherapy (mannitol or hypertonic saline), endotracheal intubation, and mechanical ventilation. Under appropriate circumstances, decompressive craniectomy may be warranted to improve outcome or to prevent death.
- Hacke W, Schwab S, Horn M, et al.: ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996, 53:309–315.
- Ryoo JW, Na DG, Kim SS, et al.: Malignant middle cerebral artery infarction in hyperacute ischemic stroke: evaluation with multiphasic perfusion computed tomography maps. J Comput Assist Tomogr 2004, 28:55–62. CrossRef
- Adams Jr HP, del Zoppo G, Alberts MJ, et al.: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38:1655–1711. CrossRef
- European Stroke Organisation (ESO) Executive Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008, 25:457–507. CrossRef
- Thomalla G, Hartmann F, Juettler E, et al.: Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study. Ann Neurol 2010, 68:435–445. CrossRef
- Oppenheim C, Samson Y, Manai R, et al.: Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 2000, 31:2175–2181.
- Vahedi K, Vicaut E, Mateo J, et al.: Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007, 38:2506–2517. CrossRef
- Yoo AJ, Barak ER, Copen WA, et al.: Combining acute diffusion-weighted imaging and mean transmit time lesion volumes with National Institutes of Health Stroke Scale Score improves the prediction of acute stroke outcome. Stroke 2010, 41:1728–1735. CrossRef
- Bhardwaj A, Harukuni I, Murphy SJ, et al.: Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke 2000, 31:1694–1701.
- Cruz J, Minoja G, Okuchi K, Facco E: Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. J Neurosurg 2004, 100:376–383. CrossRef
- Garcia-Morales EJ, Cariappa R, Parvin CA, et al.: Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med 2004, 32:986–991. CrossRef
- Koenig MA, Bryan M, Lewin III JL, et al.: Reversal of transtentorial herniation with hypertonic saline. Neurology 2008, 70:1023–1029. CrossRef
- Toung TJ, Hurn PD, Traystman RJ, Bhardwaj A: Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit Care Med 2002, 30:644–649. CrossRef
- Qizilbash N, Lewington SL, Lopez-Arrieta JM: Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2002, CD000064.
- Smith DS, Rehncrona S, Siesjo BK: Barbiturates as protective agents in brain ischemia and as free radical scavengers in vitro. Acta Physiol Scand Suppl 1980, 492:129–134.
- Stocchetti N, Maas AI, Chieregato A, van der Plas AA: Hyperventilation in head injury: a review. Chest 2005, 127:1812–1827. CrossRef
- Marion DW, Puccio A, Wisniewski SR, et al.: Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med 2002, 30:2619–2625. CrossRef
- Muizelaar JP, Marmarou A, Ward JD, et al.: Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg 1991, 75:731–739. CrossRef
- Diringer MN, Reaven NL, Funk SE, Uman GC: Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 2004, 32:1489–1495. CrossRef
- Morimoto T, Ginsberg MD, Dietrich WD, Zhao W: Hyperthermia enhances spectrin breakdown in transient focal cerebral ischemia. Brain Res 1997, 746:43–51. CrossRef
- Baena RC, Busto R, Dietrich WD, et al.: Hyperthermia delayed by 24 hours aggravates neuronal damage in rat hippocampus following global ischemia. Neurology 1997, 48:768–773.
- Olsen TS, Weber UJ, Kammersgaard LP: Therapeutic hypothermia for acute stroke. Lancet Neurol 2003, 2:410–416. CrossRef
- Schwab S, Schwarz S, Spranger M, et al.: Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998, 29:2461–2466.
- Bratton SL, Chestnut RM, Ghajar J, et al.: Guidelines for the management of severe traumatic brain injury. VI Indications for intracranial pressure monitoring J Neurotrauma 2007, 24(Suppl 1):S37–S44.
- Frank JI: Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 1995, 45:1286–1290.
- Poca MA, Benejam B, Sahuquillo J, et al.: Monitoring intracranial pressure in patients with malignant middle cerebral artery infarction: is it useful? J. Neurosurg 2010, 112:648–657. The authors studied a prospective cohort of 25 patients with a malignant MCA infarction consecutively admitted to an intensive care unit. Intracranial pressure readings were evaluated and correlated with pupillary abnormalities and with midline shift and ischemic tissue volume evaluated in the CT scan. The authors showed that in patients with MCI, pupillary abnormalities and severe brainstem compression may be present despite normal ICP values. Therefore, continuous ICP monitoring cannot substitute for close clinical and radiologic follow-up in the management of these patients. CrossRef
- Schwab S, Aschoff A, Spranger M, et al.: The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology 1996, 47:393–398.
- Bratton SL, Chestnut RM, Ghajar J, et al.: Guidelines for the management of severe traumatic brain injury. VII. Intracranial pressure monitoring technology. J Neurotrauma 2007, 24(Suppl 1):S45–S54.
- Poca MA, Martinez-Ricarte F, Sahuquillo J, et al.: Intracranial pressure monitoring with the Neurodur-P epidural sensor: a prospective study in patients with adult hydrocephalus or idiopathic intracranial hypertension. J Neurosurg 2008, 108:934–942. CrossRef
- Sahuquillo J, Poca MA, Arribas M, et al.: Interhemispheric supratentorial intracranial pressure gradients in head-injured patients: are they clinically important? J Neurosurg 1999, 90:16–26. CrossRef
- Vahedi K, Hofmeijer J, Juettler E, et al.: Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007, 6:215–222. CrossRef
- Benejam B, Sahuquillo J, Poca MA, et al.: Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction. J Neurol 2009, 256:1126–1133. CrossRef
- Larach DR, Larach DB, Larach MG: A life worth living: seven years after craniectomy. Neurocrit Care 2009, 11:106–111. A personal account of an academic anesthesiologist who survived the aggressive treatment of a left MCI. In this paper, the author reflects on the concept of QoL and of the importance of intensive rehabilitation after massive stroke. This paper supports reconsidering the strong bias doctors generally show regarding life and death decisions based on the presumed QoL of survivors. CrossRef
- Vahedi K: Decompressive hemicraniectomy for malignant hemispheric infarction. Curr Treat Options Neurol 2009, 11:113–119. CrossRef
- Hofmeijer J, Kappelle LJ, Algra A, et al.: Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009, 8:326–333. CrossRef
- Merenda A, DeGeorgia M: Craniectomy for acute ischemic stroke: how to apply the data to the bedside. Curr Opin Neurol 2010, 23:53–58. CrossRef
- Arac A, Blanchard V, Lee M, Steinberg GK: Assessment of outcome following decompressive craniectomy for malignant middle cerebral artery infarction in patients older than 60 years of age. Neurosurg Focus 2009, 26:E3. CrossRef
- Schirmer CM, Ackil Jr AA, Malek AM: Decompressive Craniectomy. Neurocrit Care 2008, 8:456–470. CrossRef
- Kilincer C, Asil T, Utku U, et al.: Factors affecting the outcome of decompressive craniectomy for large hemispheric infarctions: a prospective cohort study. Acta Neurochir (Wien) 2005, 147:587–594. CrossRef
- Disque C, Gahn G: Ipsilateral parenchymal hemorrhage after hemicraniectomy in a patient suffering from malignant middle cerebral artery infarction. Neurologist 2007, 13:95–97. CrossRef
- Hofmeijer J, Algra A, Kappelle LJ, van der Worp HB: Predictors of life-threatening brain edema in middle cerebral artery infarction. Cerebrovasc Dis 2008, 25:176–184. CrossRef
- Simard JM, Tsymbalyuk N, Tsymbalyuk O, et al.: Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke 2010, 41:531–537. CrossRef
- Gerriets T, Stolz E, Konig S, et al.: Sonographic monitoring of midline shift in space-occupying stroke: an early outcome predictor. Stroke 2001, 32:442–447.
- Mori K, Nakao Y, Yamamoto T, Maeda M: Early external decompressive craniectomy with duroplasty improves functional recovery in patients with massive hemispheric embolic infarction: timing and indication of decompressive surgery for malignant cerebral infarction. Surg Neurol 2004, 62:420–429.
- Chen C, Carter BS: Hemicraniectomy for massive cerebral infarction. Top Stroke Rehabil 2004, 11:7–11. CrossRef
- Huh JS, Shin HS, Shin JJ, et al.: Surgical management of massive cerebral infarction. J Korean Neurosurg Soc 2007, 42:331–336. CrossRef
- Kim KT, Park JK, Kang SG, et al.: Comparison of the effect of decompressive craniectomy on different neurosurgical diseases. Acta Neurochir (Wien) 2009, 151:21–30. CrossRef
- Reddy AK, Saradhi V, Panigrahi M, et al.: Decompressive craniectomy for stroke: indications and results. Neurol India 2002, 50(Suppl):S66–S69.
- Manawadu D, Quateen A, Findlay JM: Hemicraniectomy for massive middle cerebral artery infarction: a review. Can J Neurol Sci 2008, 35:544–550.
- Yao Y, Mao Y, Zhou L: Decompressive craniectomy for massive cerebral infarction with enlarged cruciate duraplasty. Acta Neurochir (Wien) 2007, 149:1219–1221. CrossRef
- Managing Malignant Cerebral Infarction
Current Treatment Options in Neurology
Volume 13, Issue 2 , pp 217-229
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Neurosurgery, University of Maryland School of Medicine, 22 S. Greene St., Suite S12D, Baltimore, MD, 21201-1595, USA
- 2. Department of Neurosurgery, Hospital Universitario Vall d’Hebron, Universitat Autònoma de Barcelona, 08035, Barcelona, Spain
- 3. Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, 20201, USA
- 4. Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA